Open AccessTemporary Vitelliform Regression After Intravitreal Ranibizumab Injection for Macular Neovascularization Complicating Best Disease
Author(s) -
Alaa E. Fayed
Publication year - 2022
Publication title -
international medical case reports journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.198
H-Index - 11
ISSN - 1179-142X
DOI - 10.2147/imcrj.s383541
Subject(s) - medicine , metamorphopsia , ranibizumab , ophthalmology , choroidal neovascularization , lipofuscin , fundus (uterus) , macular degeneration , bevacizumab , retinal , surgery , pathology , chemotherapy
In this report, we present a case of a 12-year-old boy with Best vitelliform macular dystrophy (BVMD) complicated by macular neovascularization (MNV) and treated with two intravitreal ranibizumab injections. We document an unusual temporary regression of his vitelliform deposits and describe a 2-year follow-up course through multimodal imaging.